title: Acute myelogenous leukemia in a patient receiving etanercept for psoriasis.
authors.forename: Claude
authors.initials: C
authors.lastname: Bachmeyer
authors.forename: Brigitte
authors.initials: B
authors.lastname: Thiolière
authors.forename: Kiarash
authors.initials: K
authors.lastname: Khosrotehrani
authors.forename: Elie
authors.initials: E
authors.lastname: Cattan
mesh_terms: D000328:Adult; D000068800:Etanercept; D005221:Fatigue / Q000209:etiology; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects* / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced* / Q000175:diagnosis; D007958:Leukocyte Count; D008297:Male; D011565:Psoriasis / Q000150:complications / Q000188:drug therapy*; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept